Hamilton Thorne (CVE:HTL) Stock Price Up 4.3% – What’s Next?

Hamilton Thorne Ltd. (CVE:HTL)’s stock price rose 4.3% on Monday . The stock traded as high as C$1.45 and last traded at C$1.45. 25,700 shares were traded during trading, a decline of 27% from the average daily volume of 35,118 shares. The stock had previously closed at C$1.39.

Hamilton Thorne Stock Performance

The firm has a market cap of C$149.69 million, a P/E ratio of 58.94 and a beta of 0.54. The stock’s 50 day moving average is C$1.45 and its two-hundred day moving average is C$1.45. The company has a debt-to-equity ratio of 43.24, a current ratio of 2.04 and a quick ratio of 2.25.

Hamilton Thorne Company Profile

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets. The company also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services.